drugset / Trial / NCT00208091
Quantifying Musical Performance After Treatment With Myobloc in Musician's Dystonia
NaSingle-groupOpen-labelTreatment
Summary
This study uses a computerized method of musical instrument digital interface (MIDI) quantification of performance before and after treatment with botulinum toxin type B (Myobloc ®, Solstice Neurosciences). Myobloc is a purified and diluted form of botulinum toxin used medically to relax unwanted muscle spasms and movements. The aim of the study is to determine the feasibility of quantifying change in performance following treatment.
Timeline
- Start
- 2003-04
- Primary completion
- 2008-05
- Completion
- 2008-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Botulinum Toxin Type B | Unknown | 500 iu | Intramuscular |